Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AABP, AAER, accident, AECP, aflibercept, AISN, ALEN, Allergy, Alliance, ambition, AMD, AMP, amplify, amy, andChief, antibribery, anticorruption, antikickback, antiresorptive, arrive, Arthrex, autumn, AVEN, avoid, avoided, AVSOLA, backdoor, background, backlog, BARDA, BEIJERINCK, Biden, Biomedical, black, Blaylock, blended, BNP, body, BofA, bond, boosting, border, broadened, BSA, Businesswomen, calcimimetic, Career, Chinese, Cir, clarification, clear, coalition, CodeBreaK, cohort, college, combat, compulsory, concurrently, Connecticut, constitutionality, coordinated, copay, COVID, Crohn, culture, curfew, cutoff, cybersecurity, daily, deal, deceleration, dedesignate, deeper, Deficiency, defray, degeneration, dental, deplete, Deutsche, diagnosed, diminish, disciplined, dissemination, distancing, docetaxel, downturn, ease, ebb, ecosystem, edema, elderly, emphasize, Empowered, encompassing, endothelial, enduring, England, exacerbated, exacerbation, exempted, EYLEA, Fc, featured, Fed, fell, fleet, fluidity, foreseeable, foster, futility, globe, goal, Grygiel, Hampshire, healthy, HGRAC, HIV, hospital, hospitalized, ICOSL, ICS, IIIB, immune, immunodeficiency, immunosuppressive, impossible, incentivize, incident, Indian, inhaled, injury, inserted, instructing, intelligence, interfering, interlocutory, intermittent, internet, investee, joinder, Journal, KANJINTI, learning, left, legitimate, LGBTQ, linda, lockdown, logistical, louie, lp, macular, magnitude, makeup, manipulated, Maryland, MBA, medium, MFN, microscopic, mind, Minnesota, mission, mobile, motivate, motivating, multicenter, myriad, Nancy, nationwide, navigable, navigate, NAVIGATOR, NDA, neovascular, Nephew, neutrality, NIAID, nonbiologic, nonfederal, NYVEPRIA, occlusion, occupancy, OCS, OECD, Olpasiran, OneTen, onset, ORR, outbreak, output, outreach, overcome, overseen, pandemic, PASI, paused, pausing, physically, portal, postmarketing, precipitate, precipitated, prepaid, prepandemic, PRIDE, proliferation, proportion, proportionate, protocol, Purple, pushed, quartile, RBC, reassessment, recession, recommenced, redemption, reimpose, remote, remotely, renamed, representation, resource, respiratory, resurgence, resurgent, retaliatory, retinal, retinopathy, reverification, reward, rheumatology, RIABNITM, RINVOQ, RNA, root, RTOR, School, score, semiannual, Shank, Siebert, signification, siRNA, Smith, SoC, softened, sotorasib, speaker, sPGA, spread, Stafford, stakeholder, static, STELARA, Stivarga, strain, Subcontinent, surface, surge, tackle, talent, TBA, temperature, threat, timeline, Tokyo, training, trajectory, transmission, travel, turnover, UCLA, UDENYCA, unamortized, underemployment, underrepresentation, unemployment, uninsured, ustekinumab, vaccination, Van, vascular, VEGFR, vein, verified, virtual, Warehouse, Wegener, wet, wider, winter, workplace, writ, Xeljanz
Removed:
AAA, advisory, Alzheimer, amyloid, atopic, augment, BACE, BLA, cardiac, construing, Cynthia, damage, decided, deCODE, deducting, Dermatology, Dezima, discontinuation, footprint, force, Galenica, Genentech, genome, grew, henderson, hold, Hope, hyperparathyroidism, impacting, Leonard, lessen, lesser, loan, margin, meline, Merck, Mimpara, MIRCERA, moot, moved, mutually, myosin, narrow, noncompliance, overhaul, pain, patentability, Patton, presidential, PROCRIT, properly, propose, reacquired, rebecca, reshaping, retained, revalue, SCAN, Schaeffer, sector, Servier, showing, sNDA, sorafenib, threshold, track, validation, vitamin
Filing tables
Filing exhibits
- 10-K Annual report
- 4.33 Description of Securities
- 10.4 Form of Grant of Stock Option Agreement
- 10.5 Form of Restricted Stock Unit Agreement
- 10.7 Form of Performance Unit Agreement
- 10.8 Director Equity Incentive Program
- 10.50 Amendment No. 7 to the Collaboration Agreement Between Amgen and Astrazeneca
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
- Download Excel data file
- View Excel data file
Related press release
Associated AMGN transcripts
AMGN similar filings
Filing view
External links